• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Gilead partnering with Cartography Biosciences to discover cancer therapies

cafead

Administrator
Staff member
  • cafead   May 28, 2024 at 10:42: AM
via Gilead Sciences (NASDAQ:GILD) has agreed to collaborate with Cartography Biosciences to develop new therapies for triple-negative breast cancer and adenocarcinoma, the most common form of non-small cell lung cancer.

article source